This week TV3’s Newshub shared a piece on Jimmy King, the first New Zealander with MND to access Tofersen. Tofersen is an investigational drug developed by Biogen to treat SOD1-type…
Your Search: tofersen
Motor Neurone Disease: investigational drug granted accelerated approval
…with no treatment or cure available, it is a terrifying fate. Tofersen (brand name Qalsody) is an investigational drug developed by the company Biogen to treat MND caused by a…
“The Australia and New Zealand MND Research symposium gave me hope”
…cure. While a cure is expected to be decades away, more effective treatments feel a lot closer. Tofersen for SOD-1 gene mutation is a big step forward. There is an…
Newsletters
…stories from the frontline MND Action Month – take the ice bucket challenge or host a cuppa tea Spotlight on: SOD1 type MND Personal story: Tofersen a game-changer A big…